Tela Bio Inc (TELA)

Name: Tela Bio Inc (TELA) Share Price Today, Stock Analysis, Annual Report | Value Research
Brand: Tela Bio Inc (TELA)

Stock Card

$0.87

$0.03 (4.20%)

As on 09-Sep-2026 12:32EDT

Market cap

$37 Mln

Revenue (TTM)

$80 Mln

P/E Ratio

P/B Ratio

7.3

Div. Yield

0 %

Tela Bio Inc (TELA) Share Price

Compare

High: Low: Return:

Price P/E Ratio P/B Ratio

Stock Range

Today’s Range

Low: 0.83 High: 0.89

52 Week Range

Low: 0.50 High: 1.73

Liquidity

Low Moderate High

Fundamentals

Net Profit (TTM)

$0 Mln
ROE

-6.2 %
ROCE

-- %
Industry P/E

46.09
EV/EBITDA

-5
Debt to Equity

-3.5
Book Value

$--
EPS

$-0.8
Face value

--
Shares outstanding

44,894,757

7 Years Aggregate

CFO

$-198.31 Mln

EBITDA

$-190.70 Mln

Net Profit

$-227.22 Mln

Company	YTD	1 Month	3 Months	1 Year	3 Years	5 Years	10 Years
Tela Bio Inc (TELA)	-26.7	-0.6	1.8	-46.6	-54.1	-41.4	--
BSE Sensex	-11.7	-4.8	1.7	-7.5	3.9	5.1	9.9
S&P Small-Cap 600^#	-5.8	-5.3	-13.7	-6.3	5.3	3.0	5.5

As on 09-Sep-2026 | #As on 26-Oct-2023

Company	2025	2024	2023	2022	2021	2020
Tela Bio Inc (TELA)	-60.9	-54.1	-42.4	-10.2	-14.9	16.1
S&P Small-Cap 600	4.0	7.0	13.9	-17.4	25.3	9.6
BSE Sensex	9.1	8.1	18.7	4.4	22.0	15.8

Essential Checks

View Details

Is there a threat to the company's solvency?

Can creative accounting be detected through the financial numbers?

How did the company perform in the last one year?

Financials

View Details

Key Ratios

View Details

Peers

View Details

Company	Price ($)	Market Cap ($ Mln)	Revenue (TTM)	Net Profit (TTM)	OPM (%)	ROE (%)	P/E	P/B
Tela Bio Inc (TELA)	0.9	36.9	79.9	-41.2	-42.5	--	--	7.3
10X Genomics Inc (TXG)	66.5	8,162.7	616.9	-75.1	1.7	-9.3	--	10.0
Avantor (AVTR)	14.9	10,125.1	6,561.1	-578.0	-4.5	-10.3	--	1.8
Bio-Rad Laboratories	365.1	9,761.6	2,589.3	222.4	-6.0	3	44.5	1.4
Bruker (BRKR)	54.4	8,913.0	3,499.6	-71.2	0.5	-3.2	--	3.8
Glaukos Corp (GKOS)	181.9	10,637.8	612.8	-188.1	-30.6	-28.1	--	15.3
Lantheus Holdings (LNTH)	100.9	6,590.6	1,556.3	275.3	24.6	22.9	24.2	5.0
Penumbra (PEN)	319.6	12,649.5	1,504.9	160.6	13.6	10.9	79.3	8.3
Repligen (RGEN)	167.4	9,458.6	785.1	41.5	9.9	2	232.8	4.6
Smith & Nephew SNATS - ADR	27.7	12,007.0	6,164.0	625.0	13.0	11.8	19.5	2.3

Shareholding Pattern

View Details

About Tela Bio Inc (TELA)

TELA Bio, Inc., a commercial-stage medical technology company, focuses on providing soft-tissue reconstruction solutions that optimize clinical outcomes by prioritizing the preservation and restoration of the patient's anatomy. The company provides a... portfolio of OviTex Reinforced Tissue Matrix (OviTex) products for hernia repair and abdominal wall reconstruction; and OviTex PRS Reinforced Tissue Matrix products to address the unmet needs in plastic and reconstructive surgery, as well as OviTex for Laparoscopic and Robotic Procedures, a sterile reinforced tissue matrix derived from ovine rumen with polypropylene, polyglycolic acid, and polylactic-co-glycolic acid designed to be used in laparoscopic and robotic-assisted hernia surgical repairs. It markets its products through a single direct sales force, principally in the United States. TELA Bio, Inc. was incorporated in 2012 and is headquartered in Malvern, Pennsylvania. Read more

Co-founder, President, CEO & Director

Mr. Antony Koblish
Co-founder, President, CEO & Director

Mr. Antony Koblish
Headquarters

Malvern, PA
Website

https://www.telabio.com

FAQs for Tela Bio Inc (TELA)

What is the current share price of Tela Bio Inc (TELA) Today?

The share price of Tela Bio Inc (TELA) is $0.87 (NASDAQ) as of 09-Sep-2026 12:32 EDT. Tela Bio Inc (TELA) has given a return of -54.11% in the last 3 years.

What is the current PB & PE ratio of Tela Bio Inc (TELA)?

Since, TTM earnings of Tela Bio Inc (TELA) is negative, P/E ratio is not available.
The P/B ratio of Tela Bio Inc (TELA) is 7.30 times as on 04-Sep-2026, a 93 premium to its peers’ median range of 3.78 times.

PE & PB ratio at the end of financial year.